US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy
By: theblockbeats.news|2025/08/04 13:02:14
BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.
This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.
The Ether Machine has announced an increase in holdings of 10,605 ETH, bringing the total holdings to 345,362 ETH.
US Stock DFDV Announces Increase in Holding of 110,000 SOL, Bringing Total Holdings to 1,293,000 SOL
You may also like
Share
Gainers
Latest Crypto News
09:45
A certain whale has accumulated 2.33 million LINK over the past six months, currently facing an unrealized loss of $10.5 million
09:45
CoinShares: Digital Asset Investment Products Saw $1.07 Billion in Net Inflows Last Week
09:45
Abraxas Capital has allocated half of its funds to purchase HYPE spot, with a position reaching $56 million.
09:15
BNP Paribas: Fed to Continue Cutting Interest Rates Next Year, Room for Further Decline in US Bond Yields
09:15
The Government of the Kingdom of Bhutan transferred 175.44 ETH, approximately $49,700 USD.
Read more
Community
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Services:support@weex.com